MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Background: MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apoptosis. MiR-221 and miR-222 were discovered to induce cell growth and cell cycle progression via direct targeting of p27 and p57 in various human malignancies. However, the roles of miR-221 and miR-222 have not been reported in human gastric cancer. In this study, we examined the impact of miR-221 and miR-222 on human gastric cancer cells, and identified target genes for miR-221 and miR-222 that might mediate their biology. Methods: The human gastric cancer cell line SGC7901 was transfected with AS-miR-221/222 or transduced with pMSCV-miR-221/222 to knockdown or restore expression of miR-221 and miR-222, respectively. The effects of miR-221 and miR-222 were then assessed by cell viability, cell cycle analysis, apoptosis, transwell, and clonogenic assay. Potential target genes were identified by Western blot and luciferase reporter assay. Results: Upregulation of miR-221 and miR-222 induced the malignant phenotype of SGC7901 cells, whereas knockdown of miR-221 and miR-222 reversed this phenotype via induction of PTEN expression. In addition, knockdonwn of miR-221 and miR-222 inhibited cell growth and invasion and increased the radiosensitivity of SGC7901 cells. Notably, the seed sequence of miR-221 and miR-222 matched the 3'UTR of PTEN, and introducing a PTEN cDNA without the 3'UTR into SGC7901 cells abrogated the miR-221 and miR-222-induced malignant phenotype. PTEN-3'UTR luciferase reporter assay confirmed PTEN as a direct target of miR-221 and miR-222. Conclusion: These results demonstrate that miR-221 and miR-222 regulate radiosensitivity, and cell growth and invasion of SGC7901 cells, possibly via direct modulation of PTEN expression. Our study suggests that inhibition of miR-221 and miR-222 might form a novel therapeutic strategy for human gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S.-S., Ngankeu, A., Taccioli, C., Pichiorri, F., Alder, H., Secchiero, P., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.014 · Cited by 733
RetractedMicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps
Chi, S. W., Zang, J. B., Mele, A., & Darnell, R. B. (2009) · Nature · doi:10.1038/nature08170 · Cited by 1,791
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Tay, Y., Zhang, J., Thomson, A. M., Lim, B., & Rigoutsos, I. (2008) · Nature · doi:10.1038/nature07299 · Cited by 1,385
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., & Shimotohno, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209283 · Cited by 1,147
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Brognard, J., Clark, A. S., Ni, Y., & Dennis, P. A. (2001) · PubMed · Cited by 987
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
Julien-Grille, S., Bellacosa, A., Upson, J. J., Klein–Szanto, A. J., Roy, F. M. V., Lee‐Kwon, W., Donowitz, M., Tsichlis, P. N., & Larue, L. (2003) · PubMed · Cited by 701
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
Fornari, F., Gramantieri, L., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., Grazi, G. L., Giovannini, C., Croce, C. M., Bolondi, L., et al. (2008) · Oncogene · doi:10.1038/onc.2008.178 · Cited by 639
High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma
Metzler, M., Wilda, M., Busch, K., Viehmann, S., & Borkhardt, A. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10316 · Cited by 543
Kim, Y.-K., Yu, J., Han, T. S., Park, S.-Y., Namkoong, B., Kim, D. H., Hur, K., Yoo, M.-W., Lee, H.-J., Yang, H.-K., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp002 · Cited by 470
Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues
Guo, J., Miao, Y., Xiao, B., Huan, R., Jiang, Z., Meng, D., & Wang, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05666.x · Cited by 446
PTEN-deficient intestinal stem cells initiate intestinal polyposis
He, X. C., Yin, T., Grindley, J. C., Tian, Q., Sato, T., Tao, W. A., Dirisina, R., Porter-Westpfahl, K. S., Hembree, M., Johnson, T., et al. (2007) · Nature Genetics · doi:10.1038/ng1928 · Cited by 417
Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., & Klinge, C. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp117 · Cited by 391
Bandres, E., Bitarte, N., Arias, F., Agorreta, J., Fortes, P., Agirre, X., Zarate, R., Diaz-Gonzalez, J. A., Ramirez, N., Sola, J. J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1818 · Cited by 346
Moriyama, T., Ohuchida, K., Mizumoto, K., Yu, J., Sato, N., Nabae, T., Takahata, S., Toma, H., Nagai, E., & Tanaka, M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0592 · Cited by 342
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
Liu, T., Tang, H., Lang, Y., Liu, M., & Li, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.003 · Cited by 334
MicroRNA and cancer – focus on apoptosis
Wang, Y., & Lee, C. G. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00510.x · Cited by 330
Inhibition of microRNA with antisense oligonucleotides
Esau, C. C. (2008) · Methods · doi:10.1016/j.ymeth.2007.11.001 · Cited by 257
Itoh, N., Semba, S., Ito, M., Takeda, H., Kawata, S., & Yamakawa, M. (2002) · Cancer · doi:10.1002/cncr.10591 · Cited by 243
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
Talotta, F., Cimmino, A., Matarazzo, M. R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., & Verde, P. (2009) · Oncogene · doi:10.1038/onc.2008.370 · Cited by 242
Qi, L., Bart, J., Tan, L. P., Platteel, I., Sluis, T. V. D., Huitema, S., Harms, G., Fu, L., Hollema, H., & Berg, A. V. D. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-163 · Cited by 229
Vasko, V, Saji, M., Hardy, E., Kruhlak, M., Larin, A., Savchenko, V, Miyakawa, M., Isozaki, O., Murakami, H., Tsushima, T., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015339 · Cited by 211
Yu, H., Ai, Y., Yu, L., Zhou, X., Liu, J., Li, J., Xu, X., Liu, S., Chen, J., Liu, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23049 · Cited by 203
Vinciguerra, M., Sgroi, A., Veyrat-Durebex, C., Rubbia-Brandt, L., Buhler, L. H., & Foti, M. (2009) · Hepatology · doi:10.1002/hep.22737 · Cited by 198
Byun, D., Cho, K., Ryu, B., Lee, M., Park, J., Chae, K., Kim, H., & Chi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.10962 · Cited by 184
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer
Oki, E., Baba, H., Tokunaga, E., Nakamura, T., Ueda, N., Futatsugi, M., Mashino, K., Yamamoto, M., Ikebe, M., Kakeji, Y., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21170 · Cited by 173
Lu, Y., Xiao, J., Lin, H., Bai, Y., Luo, X., Wang, Z., & Yang, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1053 · Cited by 150
Jiang, Z., Pore, N., Cerniglia, G. J., Mick, R., Georgescu, M. M., Bernhard, E. J., Hahn, S. M., Gupta, A., & Maity, A. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3398 · Cited by 139
Rojo, F., Tabernero, J., Albanell, J., Van Cutsem, E., Ohtsu, A., Doi, T., Koizumi, W., Shirao, K., Takiuchi, H., Cajal, S. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2424 · Cited by 137
miR-221/222 promote malignant progression of glioma through activation of the Akt pathway
Kang (2010) · International Journal of Oncology · doi:10.3892/ijo_00000570 · Cited by 130
Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer
Liao, Y., Grobholz, R., Abel, U. R., Trojan, L., Michel, M. S., Angel, P. E., & Mayer, D. (2003) · International Journal of Cancer · doi:10.1002/ijc.11471 · Cited by 127
Kang (2009) · International Journal of Oncology · doi:10.3892/ijo_00000296 · Cited by 125
Tanno, S., Yanagawa, N., Habiro, A., Koizumi, K., Nakano, Y., Osanai, M., Mizukami, Y., Okumura, T., Testa, J. R., & Kohgo, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1788 · Cited by 113
Sun, Y., Clair, D. K. S., Fang, F., Warren, G. W., Rangnekar, V. M., Crooks, P. A., & Clair, W. H. S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0186 · Cited by 94
Tumours and tremors: how PTEN regulation underlies both
Kim, R. H., & Mak, T. W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602994 · Cited by 82
Okudela, K., Hayashi, H., Ito, T., Yazawa, T., Suzuki, T., Nakane, Y., Sato, H., Ishi, H., KeQin, X., Masuda, A., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63100-8 · Cited by 72
Therapeutic Efficacy of PUMA for Malignant Glioma Cells Regardless of p53 Status
Ito, H., Kanzawa, T., Miyoshi, T., Hirohata, S., Kyo, S., Iwamaru, A., Aoki, H., Kondo, Y., & Kondo, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.685 · Cited by 64
Activated Akt as an indicator of prognosis in gastric cancer
Cinti, C., Vindigni, C., Zamparelli, A., Sala, D. L., Epistolato, M. C., Marrelli, D., Cevenini, G., & Tosi, P. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0676-8 · Cited by 63
A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok
Zhang (2009) · International Journal of Oncology · doi:10.3892/ijo_00000241 · Cited by 60
DNA methyltransferase inhibitor 5‐aza‐CdR enhances the radiosensitivity of gastric cancer cells
Qiu, H., Yashiro, M., Shinto, O., Matsuzaki, T., & Hirakawa, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01004.x · Cited by 60
Pappas, G., Zumstein, L. A., Munshi, A., Hobbs, M. L., & Meyn, R. E. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701050 · Cited by 59
Estradiol downregulates miR-21 expression and miR-21 gene targets in MCF-7 breast cancer cells.
Wickramasinghe, N. S. M. D., Manavalan, T. T., Riggs, K., Li, Y., & Klinge, C. M. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-3051 · Cited by 45
Park, J. K., Jung, H., Park, S. H., Kang, S. Y., Yi, M.-R., Um, H., & Hong, S. H. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.069 · Cited by 40
Honjo, S., Osaki, M., Ardyanto, T. D., Hiramatsu, T., Maeta, N., & Ito, H. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.141 · Cited by 26
Cited by
Akt, FoxO and regulation of apoptosis
Zhang, X., Tang, N., Hadden, T. J., & Rishi, A. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.010 · Cited by 1,103
Han, J., Wang, J.-Z., Yang, X., Yu, H., Zhou, R., Lu, H.-C., Yuan, W.-B., Lu, J.-C., Zhou, Z.-J., Lu, Q., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1036-9 · Cited by 709
Noncoding RNAs in gastric cancer: implications for drug resistance
Wei, L., Sun, J., Zhang, N., Zheng, Y., Wang, X., Lv, L., Liu, J., Xu, Y., Shen, Y., & Yang, M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01185-7 · Cited by 468
Serum microRNAs as non-invasive biomarkers for cancer
Brase, J. C., Wuttig, D., Kuner, R., & Sültmann, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-306 · Cited by 421
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
Garofalo, M., Quintavalle, C., Romano, G., M. Croce, C., & Condorelli, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376170 · Cited by 331
Metadata
- Authors
- Chun-zhi, Z., Lei, H., An-ling, Z., Yan-chao, F., Xiao, Y., Guang-xiu, W., Zhi-fan, J., Pei-yu, P., Qing-yu, Z., & Chun-sheng, K.
- Venue
- BMC Cancer
- Published
- 2010-07-12
- Volume
- 10
- Issue
- 1
- Pages
- 367-367
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W1887368958
- Cited by
- 382
- References
- 54
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.